Mon, Feb 26, 2024 3:09 PM
Why India’s consumption expenditure data is good news for investors
A Flip by Shubhangi Gupta
Gland Pharma shares gained 3.5% on Tuesday, May 7, after the company announced it had received approval from the United States Food and Drug Administration (USFDA) for its Plerixafor Injection. The injection is used to treat certain types of cancer. In a stock exchange filing, the pharma company said that Plerixafor is a bioequivalent and therapeutically equivalent to Sanofi India’s.
Open Flip
Crypto Venture Capital Funding Surpasses $1 Billion for Second Consecutive Month. Crypto venture capital funding has exceeded $1 billion, signaling sustained investor interest in the industry. In April, a total of $1.02 billion was raised across 161 investment rounds, slightly lower than the $1.09 billion recorded in March from 186 rounds. Several notable fundraises contributed to this milestone.
Open Flip
Both at the level of indices and market breadth, volatility is back. As the valuations are still in high zone and even a small correction can lead to sharp cut in stock prices it would be better for any investor in a corrective phase that fresh investment should be made in large cap stocks as there is a possibility that they would see less damage in correction which might continue for more time.
Open Flip
